These results demonstrate that cGAS-STING signaling is not molecularly impaired in melanoma-conditioned pDCs; however, data using STING agonist confirmed a defective pDCs activation by melanoma-derived soluble factors (Figures 4C, H). The gene discussed is STING1; the disease is melanoma.